We are live on ! Find out more
IART icon

Integra LifeSciences
IART

251 hedge funds and large institutions have $4.8B invested in Integra LifeSciences in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 92 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 15

40% more capital invested

Capital invested by funds: $3.43B → $4.8B (+$1.38B)

6% more funds holding

Funds holding: 237 → 251 (+14)

1.68% more ownership

Funds ownership: 86.29% → 87.97% (+1.7%)

10% less repeat investments, than reductions

Existing positions increased: 83 | Existing positions reduced: 92

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

37% less call options, than puts

Call options by funds: $2.61M | Put options by funds: $4.13M

Holders
251
Holders Change
+14
Holders Change %
+5.91%
% of All Funds
4.44%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
31
Increased
83
Reduced
92
Closed
15
Calls
$2.61M
Puts
$4.13M
Net Calls
-$1.52M
Net Calls Change
-$1.86M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$77.6M
2
EVM
Eaton Vance Management
Massachusetts
+$42.7M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$30.8M
4
CB
Cooke & Bieler
Pennsylvania
+$13.2M
5
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$11.1M

Top Sellers

1
Capital Research Global Investors
Capital Research Global Investors
California
-$38.9M
2
Brown Advisory
Brown Advisory
Maryland
-$24.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.7M
4
ECM
Endurant Capital Management
California
-$13.3M
5
Goldman Sachs
Goldman Sachs
New York
-$10.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$601M +$77.6M +1,442,250 +18%
Capital Research Global Investors
2
Capital Research Global Investors
California
$535M -$38.9M -722,295 -8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$420M +$5.04M +93,571 +1%
CIP
4
Champlain Investment Partners
Vermont
$419M +$10.1M +187,445 +3%
BlackRock
5
BlackRock
New York
$417M +$552K +10,249 +0.2%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$300M +$30.8M +572,291 +14%
CB
7
Cooke & Bieler
Pennsylvania
$176M +$13.2M +244,503 +10%
ClearBridge Investments
8
ClearBridge Investments
New York
$167M -$940K -17,473 -0.7%
EVM
9
Eaton Vance Management
Massachusetts
$161M +$42.7M +792,588 +47%
State Street
10
State Street
Massachusetts
$114M -$1.26M -23,433 -1%
Macquarie Group
11
Macquarie Group
Australia
$82.7M +$8.44M +156,838 +14%
ACM
12
Atlanta Capital Management
Georgia
$71.9M -$3.26M -60,591 -5%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$58.7M +$1.22M +22,722 +3%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$58.6M +$2.56M +47,555 +6%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$57.9M +$226K +4,191 +0.5%
Wells Fargo
16
Wells Fargo
California
$55.2M +$4.71M +87,492 +11%
Norges Bank
17
Norges Bank
Norway
$46.3M +$4.56M +84,817 +13%
Northern Trust
18
Northern Trust
Illinois
$45.6M +$2.74K +51 +0%
ACH
19
ArrowMark Colorado Holdings
Colorado
$44.2M +$3.57M +66,281 +11%
Fisher Asset Management
20
Fisher Asset Management
Washington
$43.9M +$220K +4,083 +0.6%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$43.8M -$3.3M -61,247 -8%
GKIM
22
GW&K Investment Management
Massachusetts
$40.6M +$91.3K +1,697 +0.3%
Goldman Sachs
23
Goldman Sachs
New York
$36M -$10.3M -190,774 -26%
Charles Schwab
24
Charles Schwab
California
$35.9M -$64.4K -1,196 -0.2%
TCM
25
Tributary Capital Management
Nebraska
$34.9M +$1.27M +23,517 +5%
1
2 3 4 5

IART Hedge Fund Activity: Q4 2020 in Review

251 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2020, worth a combined $4.8B — up 40% from $3.43B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new IART positions and 15 closed out — a net gain of 16 holders — while 83 added to existing stakes and 92 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $77.6M. The largest seller was Capital Research Global Investors, cutting an estimated $38.9M.

  • 251 institutional investors held Integra LifeSciences (IART) as of Q4 2020, up from 237 in Q3 2020.
  • Funds reported $4.8B of Integra LifeSciences stock for Q4 2020, up 40% quarter-over-quarter.
  • 31 funds opened new Integra LifeSciences positions in Q4 2020 and 15 closed out, a net change of +16 holders.
  • The largest Integra LifeSciences buyer in Q4 2020 was Wellington Management Group, an estimated $77.6M added.
  • The largest Integra LifeSciences seller in Q4 2020 was Capital Research Global Investors, an estimated $38.9M sold.

Based on aggregated 13F filings for Q4 2020.